AFG
TEVA icon

Atomi Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Atomi Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Buy
12,067
+649
+6% +$21.6K 0.01% 868
2026
Q1 		$344K Buy
11,418
+1,075
+10% +$34.6K 0.01% 882
2025
Q4 		$323K Buy
+10,343
New +$255K 0.01% 896

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Atomi Financial Group's TEVA Position: Q2 2026 in Review

Atomi Financial Group increased its Teva Pharmaceuticals (TEVA) stake by 5.7% in Q2 2026, buying an estimated $21.6K and bringing the position to 12,067 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #868.

Atomi Financial Group first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Atomi Financial Group held 12,067 shares of Teva Pharmaceuticals worth $409K as of Q2 2026.
  • Atomi Financial Group bought 649 Teva Pharmaceuticals shares in Q2 2026, an estimated $21.6K.
  • Teva Pharmaceuticals made up 0.01% of Atomi Financial Group's portfolio in Q2 2026, its #868 holding.
  • Atomi Financial Group first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.